To further investigate the association of survival time with E-cadherin and STYK1 expression, a final concomitant model was constructed and we found that a combinatorial pattern of high E-cadherin expression and low STYK1 predicted the better clinical prognosis in pancreatic cancer (Figure 4C, 4D). This evidence concerns the gene CDH1 and familial pancreatic carcinoma.